Background: Hepatitis C infection induces an acute and chronic liver inflammation that may lead to cirrhosis, liver failure, or hepatocarcinoma. Since the role of ␣␤ T lymphocytes in hepatitis C virus (HCV) immunopathology has been analyzed extensively, we investigated the distribution and functional activation of ␥␦ T cell subsets in chronically HCV-infected patients. Materials and Methods: Blood samples and liver biopsies from 35 patients with compensated chronic HCV infection were compared in terms of T cell subset distribution, expression of activation markers, ␥␦ T cell receptor (TCR) repertoire, and pattern of cytokine production. Moreover, we analyzed whether these immunological parameters were associated with other clinical observations (plasma viremia, ALT levels, Ishak index). Results: Differing from peripheral blood distribution, a specific compartmentalization of V␦1 T cells (p Ͻ 0.001) was observed in the liver of HCV patients. These cells rep-
Introduction
Among hepatitis viruses, hepatitis C virus (HCV) is the main factor responsible for chronic liver disease often progressing to cirrhosis and/or hepatocellular carcinoma (1, 2) . Unfortunately, the majority of HCVinfected persons develop chronic hepatitis that is difficult to eradicate with the current therapeutic protocols (2) . In contrast, less than 10% of patients with acute hepatitis B virus infection will become chronic (3). This distinct difference implies that different survival strategies of hepatitis viruses and/or different host immune responses may exist. Specifically, progression of chronic hepatitis C is characterized by a dramatic lymphocyte infiltrate in the liver (4, 5) . Several lines of evidence argue in favor of immunemediated hepatic damage triggered by infiltrating lymphocytes, rather than a direct HCV-mediated cytopatic effect in chronic hepatitis C virus infection. Further studies are required to determine which of the infiltrating T cell subset play cytotoxic or inflammatory functions that could be helpful, useless or even harmful.
Although ␥␦ T lymphocytes represent a minor population of human peripheral lymphocytes, recent studies have demonstrated a predominant localization of lymphocytes expressing the ␥␦ T cell receptors (TCR) in the liver (6, 7, 8) . Moreover, gd T cells mediate a potent antiviral response against different viruses (9) . In peripheral blood, the majority of ␥␦ T cells express the V␥9V␦2 rearrangement. This subset exerts potent cytotoxic activity controlled by specific natural killer (NK)-receptors and may recognize nonpeptidic antigens in a major histocompatibility complex (MHC)-unrestricted manner, without the need for antigen processing (10) . The remaining fraction of ␥␦ T lymphocytes express the V␦1 chain associated with different V␥-chains (11) . V␦1 T lymphocytes were shown to proliferate in response to stimulation with antigens from cytomegalovirus (CMV) or Epstein Barr virus (EBV)-infected cells (12, 13, 14) . However, whether the stimulatory ligand is of cellular or viral origin is not defined clearly. Interestingly, the proliferative response is independent of the V␥ chain coexpressed with V␦1 (13) . In healthy donors, V␦1 T cells are distributed mainly throughout the hu-man intestinal epithelium (70-90% of intestinal ␥␦ T cells) (15) and may recognize self-antigens, such as (MIC)-A,B or CD1 molecules (16, 17) , which provide a link between antiviral immunity and autoreactivity.
In this study, the phenotype and functional characteristic of intrahepatic ␥␦ T cells were analyzed. We observed a polyclonal localization of effector/memory V␦1 ϩ T lymphocytes expressing a T helper cell type 1 (Th1) phenotype in the liver of HCV-infected persons with a necroinflammatory process. Thus, V␦1 T cells may contribute to the liver inflammation and autoreactivity frequently occurring during hepatitis C.
Materials and Methods

HCV Patients
Patients with compensated chronic HCV infection were involved in the study (mean age: 45 Ϯ 13 years; 23 males and 12 females). All patients (n ϭ 35) were from the National Institute for Infectious Diseases, L. Spallanzani, of Rome. They all had histological confirmation of chronic hepatitis and abnormal serum aminotransferase values (84 Ϯ 68 UI/mm 3 ) for at least 6 months. Specifically, a total of 35 HCVinfected patients was analyzed (30 patients untreated, 3 patients treated with interferon ␣ (IFN␣), and 2 patients with IFN␣ plus ribavirin, in accordance with international guidelines). No significant differences between treated and untreated patients were observed regarding the parameters analyzed in this study. As control patients with different liver diseases, we analyzed four persons HCV-seronegative. This control group was composed of two hepatitis B virus (HBV)-infected persons, one HBV and human immuno deficiency virus (HIV)-infected person, and one patient without viral hepatitis and HIV seronegative. Blood samples and liver biopsies were always performed for diagnostic purposes and an aliquot of the samples (10-15 mm of length) was obtained upon informed consent of the patients. The local etichal committee approved the study.
Human Peripheral Blood Mononuclear Cells (PBMC) and Intrahepatic Lymphocytes (IHL) Isolation
Blood samples were diluted volume per volume (v/v) in RPMI medium (RPMI). PBMC were separated by density gradient centrifugation (FicollHypaque, Pharmacia Biotech, Uppsala, Sweden). The number of lymphocytes/mm3 was 2474 Ϯ 530 cell/mm 3 . Liver biopsy samples were washed three times with the complete medium [RPMI 1640 supplemented with 10% heat inactivated fetal calf serum (FCS), 10 U/ml penicillin/ streptomycin] to eliminate contaminating blood lymphocytes and then manually homogenized using a 70 m filter (Becton Dickinson, Mountain View, CA). Mononuclear cells were separated by density gradient centrifugation with Ficoll-Hypaque, washed twice in the complete medium, and counted. The cell recovery was 243000 Ϯ 95000 lymphocytes/biopsy sample.
Monoclonal Antibodies
Monoclonal antibodies coupled with fluorescein (FITC), phycoerythrin (PE), phycoerythrin-cyanin 5.1 (PE-Cy5), and allophycocyanin (APC) were combined for simultaneous staining. 
Flow Cytometry
Analysis of surface antigen (Ag) expression was performed as previously described (18) . Briefly, 5 ϫ 10 5 PBMC or 5 ϫ 10 4 IHL were washed in phosphatebuffered saline (PBS) containing 1% bovine serum albumin (BSA) and 0.1% sodium azide, and were incubated for 15 min at 4ЊC with the indicated FITC-, or PE-, or PE-Cy5-, or APC-conjugated mAbs. cruitment of activated T cells, the increase of memory IHL was paralleled by an induction of HLA-DR on T lymphocytes (Fig. 1F ). The bottom graph shows that the reported higher percentage of activated/ memory T cells in the liver of HCV ϩ patients, compared with the circulating pool, which was statistically significant (p Ͻ 0.01). No differences were observed in the expression of activation markers on PBMC from healthy donors, HCVϩ patients, and HCVϪ patients with liver diseases (data not shown). Interestingly, the frequency of activated cells was increased similarly in IHL from HCVϩ or HCVϪ patients with liver diseases, compared with PBMC. Specifically, CD45RO ϩ
CD62L
Ϫ memory/activated IHL were 36.6 Ϯ 8.6% in HCVϩ patients and 46.0 Ϯ 4.9% in HCVϪ persons with liver diseases. Moreover, CD3 ϩ HLA-DR ϩ -activated IHL were 35.6 Ϯ 14.9% in HCVϩ patients and 40.0 Ϯ 16.6% in HCVϪ persons with liver diseases. Altogether, these data confirmed that liver inflammation induced a broad increase of memory/ activated intrahepatic T lymphocytes (6) .
Selective Recruitment of CD8 and V␦1 T Cells In the Liver of HCVϩ Patients
The T cell subsets infiltrating the liver of HCVinfected persons were further characterized by flow cytometry. In the liver of HCV-infected persons, the percentage of CD3 ϩ T lymphocytes was reduced slightly, compared with the peripheral blood (Table 1) . Moreover, the CD4/CD8 ratio also was inverted, with a predominance of CD8 T lymphocytes in the liver of HCV patients. Interestingly, an increased fraction of T cells expressing the ␥␦ TCR was observed in the liver of HCV patients ( Table 1 ), suggesting that this T cell subset may play a relevant role at the site of infection (6) . We then analyzed the V␦1 and V␦2 T cell subset distribution in IHL and PBMC by flow cytometry. Double-staining was performed with anti-CD3 and anti-V␦1-TCR or anti-V␦2-TCR-specific mAbs. Our observations confirmed that V␦2 T lymphocytes were the main subset of ␥␦ T cells in the peripheral blood and showed that the number of CD3 ϩ cells expressing the V␦1 TCR was increased markedly in the liver of HCVϩ patients (Table 1 and Fig. 2A ). The frequency of V␦1 T cells in PBMC was similar both in healthy donors, HCV-infected persons, and HCV-seronegative patients with other liver (1.0 Ϯ 0.2%, 0.9 Ϯ 0.6%, 1.5 Ϯ 0.2%, respectively). Moreover, the percentage of V␦1 T cells in the liver was significantly higher in HCV-infected persons vs. HCV-seronegative patients with other liver diseases (3.5 Ϯ 2.1% vs. 1.5 Ϯ 0.3% respectively, p Ͻ 0.05.), suggesting that liver infiltration by V␦1 T lymphocytes specifically was induced by HCV-infection.
Finally, we analyzed whether the increased percentage of V␦1 T cells in the liver of HCV-infected patients was associated with other clinical parameters. The percentage of peripheral V␦1 T cells correlated Samples were fixed in 1% paraformaldehyde and immediately acquired by a FACScalibur flow cytometer (Becton Dickinson). A total of 20,000 events were acquired for each sample and analyzed with the CellQuest software (Becton Dickinson).
Single-cell Analysis of Cytokine Synthesis
Cytokine production was detected by flow cytometry analysis as previously described (19) . Human IHL and PBMC were stimulated overnight with phorbol12-myristate13acetate (PMA); 50ng/ml) ϩ ionomycin (1 g/ml) . Brefeldin A (10 g/ml) was added 2 hr after from stimulation to block intracellular transport, allowing cytokine accumulation in the Golgi. Cells were washed twice in PBS, 1% BSA, and 0.1% sodium azide, and stained with mAbs specific for the membrane antigens described above (V␦1-FITC, CD8-PerCP, CD4-APC) for 15 min a 4ЊC. To permeabilize the cell membrane, samples then were fixed in PBS/1% paraformaldehyde for 10 min at 4ЊC, incubated with anti-cytokine-specific mAb (IFN-␥-PE, IL-4-PE) diluted in 1% PBS, 1% BSA, and 0.5% saponin. The cells finally were washed twice in PBS, 1% BSA, and 0.1% saponin, and acquired on a FACScalibur (Becton Dickinson). Control for nonspecific staining always was monitored with isotype-matched mAbs and nonspecific staining always was subtracted from specific results.
Results
Recruitment of CD62-L Ϫ CD45-RO ϩ Effector/Memory Cells In the Liver of HCVϩ Patients
The surface expression of markers for naive/memory cells (CD45-RA/RO and CD62-L) and human leucocyte antigen-DR (HLA-DR) were analyzed by flow cytometry on PBMC and IHL. Activation of naive T cells through TCR was followed by loss of the CD45-RA isoform and transition to the CD45-RO phenotype (20, 21, 22) . Figure 1 shows the cytometric panels from a representative HCV-infected patient. Naive lymphocytes were double-stained, expressing both CD45-RA ϩ and CD62-L ϩ (Fig. 1A  and D) . This subset represented 47% of the circulating lymphocytes (Fig. 1A) . In the liver of the same HCV-infected patient, the percentage of naive lymphocytes was reduced markedly (8.1%, Fig. 1D ), compared with the peripheral blood compartment. In contrast, memory and recently activated lymphocytes (CD45-RO ϩ CD62-L Ϫ ) (23) represented 8.8% of the circulating cells (Fig. 1B) . Interestingly, the fraction of memory/activated cells in the liver of the same HCV-infected donor increased to 36.8% (Fig. 1E) . HLA-DR was expressed constitutively at high levels on the surface of B lymphocytes (24, 25) . As shown in Figure 1C , few HLA-DR brightly positive B cells were present in the liver of HCV-infected persons. However, HLA-DR represented an activation marker for T cells and was expressed moderately on T cells upon activation (24, 25) . Consistent with a functional re- 
Cytokine Production by Intrahepatic Vd1 ϩ T Cells and Liver Injury In HCV-infected Patients
The pattern of cytokine production displayed by peripheral and intrahepatic V␦1 T cells was determined at single-cell level by intracellular staining, monitoring the production of IFN-␥ and IL-4. Th1 cells promoted inflammatory cellular responses and were biased toward IFN-␥ secretion; whereas, Th2 cells were prone to IL-4 production and favored humoral immunity. The percentage of V␦1 ϩ IFN-␥ ϩ -producing T cells was calculated among the percentage of total V␦1 ϩ T cells. As shown in Fig. 3A , a relevant fraction of V␦1 T lymphocytes released IFN-␥ upon stimulation, independent of their origin (liver tissue or peripheral blood). No difference in term of cytokine production by V␦1 T lymphocytes was observed comparing PBMC from healthy donors with HCV-infected persons (Fig. 3A) . However, an increased number of IFN-␥-producing-V␦1 T lymphocytes was observed in IHL from HCV-infected patients with high liver inflammation (Grading, Gr Ͼ 4), compared with peripheral cells or IHL from patients with moderate liver diseases (1 Ͻ Gr Ͻ 2). These observations confirmed that IHL displayed a higher frequency of Th1 effectors (27, 28) . In contrast, only a minor fraction of PBMC and IHL produced IL-4 upon stimulation (Fig. 3B) . Thus, the inflammed liver of HCV patients was enriched with V␦1 T lymphocytes displaying a Th1 phenotype.
Characterization of V␦1 T Cell Phenotype and V␥-repertoire
To investigate whether the intrahepatic V␦1 T cells were expressing particular differentiation and with a higher distribution of intrahepatic V␦1 T lymphocytes (Fig. 2B) , suggesting that V␦1 T cells entering the liver may originate from blood circulation under the influence of chemo-attractant factors (26) . Altogether, these observations suggested that V␦1 T cells may contribute to liver damage through the secretion of proinflammatory cytokines. No correlation between plasma viremia or alanine aminotransferase (ALT) levels was observed (data not shown). activation markers, we used three-color labeling with specific mAbs. In the liver of HCV patients, the majority of V␦1 T cells lose their naive phenotype typical of peripheral V␦1 T lymphocytes (CD62-L ϩ CD45-RO Ϫ ) and clearly were stained as effector/memory cells (CD62-L Ϫ CD45-RO ϩ ) (Fig. 4A) . Accordingly, liver V␦1 T lymphocytes expressed more CD95 antigen (Fig. 4A) , a member of the tumor necrosis factor/nerve growth factor-receptor (TNF/NGF-R) family that is related to programmed cell death (29, 30) . Moreover, recent studies indicated that CD95 expression on T lymphocytes reflected previous or ongoing antigenspecific activation (31) . Both peripheral and liver V␦1 T cells expressed the T cell activation marker HLA-DR (Fig. 4A) , suggesting that this subset already was activated in the peripheral blood of HCV infected persons. Furthermore, the expression of Fas antigen on V␦1 T lymphocytes was significantly higher in PBMC from HCVϩ patients, compared with healthy donors (51.0 Ϯ 15.8% vs. 9.2 Ϯ 7.6, respectively; p Ͻ 0.01). No differences were observed concerning the expression of other activation/differentiation markers (CD62L, CD45RO, HLA-DR, CD4, CD8; data not shown). Finally, we confirmed that the majority of V␦1 T lymphocytes lacked the expression of both CD4 and CD8 coreceptors (Fig. 4A) , indicating that antigen recognition by ␥␦ T cells was largely MHCindependent.
The TCR repertoire of V␦1 T cells in the liver of HCV patients then was analyzed to determine whether the increased expression of this subset in the liver was determined clonally. TCR V␦1 and V␥ usage was assessed at the protein level by flow cytometry on peripheral and liver ␥␦ T cells, using mAbs that specifically recognized each TCR V-␥ region. Both in periphery and in the liver, the V␥-gene segment usage was heterogeneous, with all variable regions represented and a slight predominance of V␥3.5-V␦1, V␥8-V␦1, and V␥9-V␦1 in the liver (Fig. 4B) . Altogether, these data indicated that the ␥␦ T cell recruitment in the liver of HCV patients was polyclonal, since the V␥-usage largely was variable.
Discussion
Chronic hepatitis C usually occurs in more than 70% of HCV-infected persons and frequently is associated with complications, such as cirrhosis and hepatocarcinoma (2) . However, the mechanisms in- tribution in the peripheral blood, we observed an intrahepatic recruitment of T cells expressing the V␦1 TCR rearrangement and a memory/activated phenotype. This T cell subset reveals an increased frequency of IFN-␥ precursors, compared with peripheral V␦1 T cells from the same donors. Moreover, the percentage of intrahepatic V␦1 T cells releasing IFN-␥ is higher in the liver of HCV-infected patients going through the necroinflammatory process, suggesting that this T cell subset may contribute to the immunopathology of HCV infection. The stimulatory ligand may to be of cellular (rather than viral) origin, and the proliferative response could be independent of the V␥-chain co-expressed with V␦1. The ligand recognized by V␦1 T lymphocytes is probably a stress antigen of cellular origin (16 (17) . Specifically, V␦1 T cells were found to proliferate in response to CD1 ϩ -presenting cells, lyse CD1c ϩ targets, and release Th1 cytokines. Recognition of CD1c is TCR-mediated, as recognition was transferred by transfection of the V␦1 TCR. The ␥␦ T cell lines and clones show highly specific, direct reactivity to CD1c proteins that is not dependent on the presence of an exogenous foreign antigen. Interestingly, CD1 molecules particularly are expressed in the liver where the hepatocytes express very low levels of classical MHC molecules (32) .
A significant increase of systemic V␦1 T cells without clonal selection previously was observed in HIV infection (33) . It is interesting to note that systemic HIV infection induces a V␦1 mobilization from tissue to the peripheral blood; whereas, the V␦1 T cell localization is preferentially hepatic during HCV infection. Moreover, the preactivated V␦1 T cells observed in the peripheral blood of HIV patients always conserve a naive phenotype (33) . In contrast, the expression of markers specific for memory cells is a common characteristic of V␦1 and all intrahepatic T cells in HCVϩ patients, confirming that CD62-L selectin is lost by lymphocytes coming from volved with HCV persistence in the infected host and the factors mediating liver injury are poorly understood. It is likely that both viral and host factors are involved in the pathogenesis of chronic hepatitis C. In contrast to the normal ␥␦ T cell dis- 
